Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ulbrich

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Journal of Drug Targeting|May 9, 2002
In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13M Kovár, J Strohalm, K Ulbrich, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 16, 2010
Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicinM Studenovsky, K Ulbrich, M Ibrahimova, et al.
Folia Microbiologica|January 1, 1983
Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers--potential hapten or drug carriersB Ríhová, K Ulbrich, J Kopecek, et al.
Polimery W Medycynie|January 1, 1979
Biological effects of some N-substituted (meth)acrylamidesO Benesová, V Plaisner, K Ulbrich, et al.
Polish Journal of Pharmacology and Pharmacy|January 1, 1980
Biological testing of monomers used for polymer synthesisO Benesová, L Sprincl, K Ulbrich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2001
New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological propertiesT Etrych, M Jelínková, B Ríhová, et al.
Journal of Biomedical Materials Research|February 1, 1994
Adsorption and activation of zymogens at solid-liquid interfaces. I. Chymotrypsinogen on alkylamino modified silica derivativesH R Yen, S Oscarsson, K Ulbrich, et al.
Biomaterials|October 1, 1980
Polymers containing enzymatically degradable bonds V. Hydrophilic polymers degradable by papainK Ulbrich, E I Zacharieva, B Obereigner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrierM St'astný, J Strohalm, D Plocová, et al.
Transplantation|June 27, 1997
Abnormal differentiation of thymocytes induced by free cyclosporine is avoided when cyclosporine bound to N-(2-hydroxypropyl)methacrylamide copolymer carrier is usedM St'astný, K Ulbrich, J Strohalm, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Journal of Drug Targeting|May 9, 2002
In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13M Kovár, J Strohalm, K Ulbrich, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 16, 2010
Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicinM Studenovsky, K Ulbrich, M Ibrahimova, et al.
Folia Microbiologica|January 1, 1983
Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers--potential hapten or drug carriersB Ríhová, K Ulbrich, J Kopecek, et al.
Polimery W Medycynie|January 1, 1979
Biological effects of some N-substituted (meth)acrylamidesO Benesová, V Plaisner, K Ulbrich, et al.
Polish Journal of Pharmacology and Pharmacy|January 1, 1980
Biological testing of monomers used for polymer synthesisO Benesová, L Sprincl, K Ulbrich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2001
New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological propertiesT Etrych, M Jelínková, B Ríhová, et al.
Journal of Biomedical Materials Research|February 1, 1994
Adsorption and activation of zymogens at solid-liquid interfaces. I. Chymotrypsinogen on alkylamino modified silica derivativesH R Yen, S Oscarsson, K Ulbrich, et al.
Biomaterials|October 1, 1980
Polymers containing enzymatically degradable bonds V. Hydrophilic polymers degradable by papainK Ulbrich, E I Zacharieva, B Obereigner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrierM St'astný, J Strohalm, D Plocová, et al.
Transplantation|June 27, 1997
Abnormal differentiation of thymocytes induced by free cyclosporine is avoided when cyclosporine bound to N-(2-hydroxypropyl)methacrylamide copolymer carrier is usedM St'astný, K Ulbrich, J Strohalm, et al.
Pageof 10